Woo
H. Shin, Ph.D., Executive Director, is the founder of SnK Associate
Inc., a business development consulting firm in the healthcare
industry, which works on numerous assignments between Asia and
North America. Dr. Shin has a wide range of experience in the
pharmaceutical industry covering areas such as patents, clinical
trials, regulatory works, as well as the drug discovery process.
With his broad networks in science, business and the financial
world, Dr. Shin not only consults with small biotech companies
to identify funding, to build strategic plans, and to partner
their technologies, but also assists investment organizations
to source and assess promising companies/technologies.
Before founding SnK Associates,
Dr. Shin was Director of Business Development and Operations
at the SK R&D Center, where he was instrumental in closing
two successful deals with Ortho-McNeal Pharmaceutical and
Janssen. At the SK R&D center, Dr. Shin started as a senior
research scientist working on automation projects for factory
processes, QC, and analytical assays. During this period,
he helped to meet the numerous technology transfer needs of
the SK group, one of the largest conglomerates in Korea.
Dr.
Shin received a BS in chemistry from Seoul National University,
Korea and a PhD' in chemistry from Michigan State University.
